Literature DB >> 30342717

Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma.

Amie Ogunsakin1, Jordan Infield1, Jeffery Zuber1, Solomon S Solomon2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30342717      PMCID： PMC7673203          DOI： 10.1016/j.amjms.2018.09.002

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN： 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  8 in total

Review 1.  Cellular and molecular mechanisms of metformin: an overview.

Authors:  Benoit Viollet; Bruno Guigas; Nieves Sanz Garcia; Jocelyne Leclerc; Marc Foretz; Fabrizio Andreelli
Journal:  Clin Sci (Lond)       Date:  2012-03       Impact factor: 6.124

2.  Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions.

Authors:  Lynn Vitale-Cross; Alfredo A Molinolo; Daniel Martin; Rania H Younis; Takashi Maruyama; Vyomesh Patel; Wanjun Chen; Abraham Schneider; J Silvio Gutkind
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-31

3.  Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells.

Authors:  S S Solomon; S K Mishra; C Cwik; B Rajanna; A E Postlethwaite
Journal:  Horm Metab Res       Date:  1997-08       Impact factor: 2.936

4.  Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer.

Authors:  Vyomesh Patel; Christina A Marsh; Robert T Dorsam; Constantinos M Mikelis; Andrius Masedunskas; Panomwat Amornphimoltham; Cherie-Ann O Nathan; Cherie Ann Nathan; Bhuvanesh Singh; Roberto Weigert; Alfredo A Molinolo; J Silvio Gutkind
Journal:  Cancer Res       Date:  2011-10-05       Impact factor: 12.701

5.  Inhibition of mammalian target of rapamycin is required for optimal antitumor effect of HER2 inhibitors against HER2-overexpressing cancer cells.

Authors:  Todd W Miller; James T Forbes; Chirayu Shah; Shelby K Wyatt; H Charles Manning; Maria G Olivares; Violeta Sanchez; Teresa C Dugger; Nara de Matos Granja; Archana Narasanna; Rebecca S Cook; J Phillip Kennedy; Craig W Lindsley; Carlos L Arteaga
Journal:  Clin Cancer Res       Date:  2009-11-24       Impact factor: 12.531

6.  Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer.

Authors:  Sao Jiralerspong; Shana L Palla; Sharon H Giordano; Funda Meric-Bernstam; Cornelia Liedtke; Chad M Barnett; Limin Hsu; Mien-Chie Hung; Gabriel N Hortobagyi; Ana M Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

Review 7.  Insulin and insulin-like growth factor signalling in neoplasia.

Authors:  Michael Pollak
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

8.  Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus.

Authors:  R William Chong; Vijaya Vasudevan; Jeffrey Zuber; Solomon S Solomon
Journal:  Am J Med Sci       Date:  2016-01-29       Impact factor: 2.378
  8 in total
  1 in total

1.  Survival Benefit of Metformin as an Adjuvant Treatment for Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yu Jiao; Dongjuan Liu; Yi Sun; Zitong Chen; Sai Liu
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.